Recent Finacing
Recent Raise
Neuvivo is a late-clinical-stage biopharmaceutical company developing NP001 and other therapeutics for ALS and neurodegenerative diseases, conducting clinical trials and preparing patient access programs from Palo Alto.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Neuvivo.
